ARN-509 is a selective AR antagonist. It affects AR signaling by blocking nuclear translocation, inhibiting tumor cell growth.
ARN-509 (Apalutamide) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for ARN-509 (Apalutamide) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- ARN-509 (Apalutamide) Mechanism of Action: Androgen Receptor Inhibition in Prostate Cancer Cell Research
- ARN-509 (Apalutamide) Clinical Trials
- ARN-509 (Apalutamide): Selectivity & Specificity
- ARN-509 (Apalutamide) Working Concentration | Cell Culture | Treatment
- ARN-509 (Apalutamide) Solubility in DMSO
- ARN-509 (Apalutamide) Stock Solution
- ARN-509 (Apalutamide) Storage
- ARN-509 (Apalutamide) Stability
- ARN-509 (Apalutamide) Combination Database
- ARN-509 (Apalutamide) Molecular Weight
- ARN-509 (Apalutamide) SMILES
- ARN-509 (Apalutamide) CAS Number
- ARN-509 (Apalutamide) Chemical Structure (2D and 3D)
- ARN-509 (Apalutamide) Sigma (AMBH2D6FA54D)? Try a better option.
- ARN-509 (Apalutamide) MedChemExpress (HY-16060)? Try a better option.
- ARN-509 (Apalutamide) APExBIO (A8364)? Try a better option.
- ARN-509 (Apalutamide) SDS｜MSDS